Luis Eduardo Ribeiro da Cunha

Luis Eduardo Ribeiro da Cunha


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
LCLuis Eduardo Ribeiro da Cunha
Luis Eduardo Ribeiro da Cunha
ASAdilson A. Stolet
Adilson A. Stolet
MSMarcelo Abrahão Strauch
Marcelo Abrahão Strauch
VPVictor Augusto Augusto Roncaglia Roncaglia Pereira
Victor Augusto Augusto Roncaglia Roncaglia Pereira
CDCarlos H. Dumard
Carlos H. Dumard
JSJerson Silva
Jerson Silva
We used the trimeric spike (S) glycoprotein (residues 1-1208) in the prefusion conformation to immunize horses for production of hyperimmune globulins against SARS-CoV-2. Serum antibody titers measured by anti-spike ELISA were above 1:1,000,000, and neutralizing antibody titer was 1:14,604 (average PRNT 90 ), which is 140-fold higher than the average neutralizing titer of plasma from three convalescent COVID-19 patients analyzed for comparison. Using the same technology routinely used for industrial production of other horse hyperimmune products, plasma from immunized animals was pepsin digested to remove the Fc portion and purified, yielding a F(ab’) 2 preparation with PRNT 90 titers 150-fold higher than the neutralizing titers in human convalescent plasma. Repeating the hyperimmunization in a second group of horses confirmed the very high neutralizing titers in serum and in a GMP clinical F(ab’) 2 lot. Virus-neutralizing activity in samples from mice that received the F(ab’) 2 preparation was detected even three days after injection, indicating an appropriate half-life for therapeutic intervention. These results supported the design of a clinical trial (identifier NCT04573855 ) to evaluate safety and efficacy of this horse F(ab’) 2 preparation.

13 February 2025 in Toxins
Verified
Journal Article
Open access
PDF file
RTRicardo Teixeira-Araujo
Ricardo Teixeira-Araujo
MSMarisa Carvalho Suarez
Marisa Carvalho Suarez
CCCarlos Corrêa-Netto
Carlos Corrêa-Netto
LCLuis Eduardo Ribeiro da Cunha
Luis Eduardo Ribeiro da Cunha
DFDebora Foguel
Debora Foguel
RUSSOLINA BENEDETA ZINGALIRUSSOLINA BENEDETA ZINGALI
RUSSOLINA BENEDETA ZINGALI
High hydrostatic pressure (HHP) has been used for viral inactivation to facilitate vaccine development when immunogenicity is maintained or even increased. In this work, we used HHP to inactivate Bothrops jararacussu venom. Our protocol promotes the loss of or decrease in many biological activities in venom. Horses were immunized with pressurized venom, and in contrast to native venom, this procedure does not induce any damage to animals. Furthermore, the serum obtained with pressurized venom efficiently neutralized all biological activities of B. jararacussu venom. Antibody titrations were higher in serum produced with pressurized venom compared to that produced by native venom, and this antivenom was not only effective against the venom of B. jararacussu but against the venom of other species and genera. In conclusion, our data show a new technique for producing hyperimmune serum using venom inactivated by HHP, and this method is associated with a reduction in toxic effects in immunized animals and higher potency.